GAMMEX® powder-free Gloves with AMT Antimicrobial Technology

Not oNly does it feel
like a secoNd skiN
it has its owN
immuNe system
kills >99% of
a hepatitis c virus surrogate
kills 99% of
hiv-1 straiN mn
kills >99.7% of
8 commoN iNfectious bacteria

Powder-free
pathogens are proven to transfer from healthcare workers to patients
and from patients to healthcare workers. 1,4
direct bacterial traNsmissioN
from the patient
in a majority of gloves with a breach
longer surgeries increase the risk of contamination
• hand bacterial counts are significantly higher with longer surgery time 2
double gloving reduces the risk of hand contamination, but does not eliminate it 4,5
• in 18% to 48% of cases, breaches occur in both the outer and inner gloves
HEALTHCArE workErS
CAN BE EXpoSED
To HArMfuL pATHoGENS
DurING SurGErY
• bacteria pass to the healthcare worker through glove breaches resulting from normal wear 1
45,5%
no bacterial
transmission
54,5%
bacterial transmission
references: 1. Hübner N-o, Goerdt A-M, Stanislawski N, et al. Bacterial migration through punctured surgical gloves under real surgical conditions. BMC Infect Dis. 2010;10:192. 2. Eklund AM, ojajärvi
J, Laitinen k, Valtonen M, werkkala kA. Glove punctures and postoperative skin flora of hands in cardiac surgery. Ann Thorac Surg. 2002;74:149-153. 3. Misteli H, weber wp, reck S, et al. Surgical
glove perforation and the risk of surgical site infection. Arch Surg. 2009;144:553-558. 4. Harnoß J-C, partecke L-I, Heidecke C-D, Hübner N-o, kramer A, Assadian o. Concentration of bacteria passing
through puncture holes in surgical gloves. Am J Infect Control. 2010;38:154-158. 5. Thomas S, Agarwal M, Mehta G. Intraoperative glove perforation—single versus double gloving in protection against
skin contamination. postgrad Med J. 2001;77:458-460. 6. Chan kY, Singh VA, oun BH, To BH. The rate of glove perforations in orthopaedic procedures: single versus double gloving. A prospective
study. Med J Malaysia. 2006;61(suppl B):3-7. 7. rabussay D, korniewicz DM. The risks and challenges of surgical glove failure. AorN J. 1997;66:867-888.

THE rISk for EXpoSurE
CAN BE EASY To MISS
the majority of glove breaches go unnoticed. 2,5,6
up to 83% of glove breaches
are Not Noticed by surgeoNs,
depending on the study 2,5,6
BrEACHES NoT
NoTICED
BY SurGEoN,%
80
60
40
20
0
CHAN kY,
et al. 6
EkLuND AM,
et al. 2
glove wear and tear, not sharps injuries, causes most breaches 6,7
• only 2% or less of all glove failures are caused by sharps injuries in most surgeries 7
• only 5% of noticed glove breaches are attributable to sharp surgical instruments in
orthopaedic surgeries 6
THoMAS S,
et al. 5
83%
69%
62%

THE fIrST SurGICAL GLoVE
THAT fIGHTS BACk
gammeX ® powder-free gloves with amt antimicrobial technology
reduce wearer exposure to pathogens.
a new level of antiviral protection
during in vitro laboratory testing, gammeX ® powder-free with amt:
• Kills >99% of a hepatitis c virus surrogate as early as 1 minute following exposure
• Kills 99% of hiv-1 strain mn * as early as 1 minute following exposure
rapid and lasting antibacterial action against a wide range of bacteria
during in vitro laboratory testing, gammeX ® powder-free with amt:
• Kills >99.7% to >99.999% of 8 common infectious bacteria causing healthcare
facility–associated infection, comprising gram-positive, gram-negative, and drug-resistant bacteria as early
as 1 and 2 minutes following exposure
in vivo laboratory testing confirms that the internal antimicrobial coating remains active against
staphylococcus aureus after 2 hours of wear.
Kills a wide range of pathogens
hiv
viruses
hepatitis c
virus surrogate
* hiv-1 strain mn is a well-studied, virulent strain of hiv-1.
mrsa
p. mirabilis
e. coli
bacteria
gram-positive
s. aureus
gram-negative
b. fragilis
e. faecium
K. oxytoca
a. baumannii

AMT ANTIMICroBIAL TECHNoLoGY
rEDEfINES pErforMANCE
ansell’s proprietary amt antimicrobial technology delivers added protection.
• ansell’s proprietary antimicrobial coating contains chlorhexidine gluconate (chg)
for antiviral and antibacterial action.
• chg is an effective antimicrobial agent found in common products such
as antiseptics and mouthwashes.
• antimicrobial action remains uncompromised when used with waterless
and water-aided surgical scrubs.
innovative technology
with a uNique structure
cross-sectioNal view
biopolymer overcoat
antimicrobial coating
containing chg
polymer coating
natural rubber latex
iNterNal surface/haNd
eXterNal surface
amt
antimicrobial technology
components
gammeX pf
base glove

MKTPRO190V1
powErfuL ANTIMICroBIAL ACTIoN
wITH A SofT TouCH
gammeX ® powder-free with amt combines antimicrobial action
with unsurpassed safety and comfort.
No distractiNg skiN irritatioN
• antimicrobial coating contains anti-irritants, moisturisers, and emollients to care for the hands
• no evidence of skin sensitisation observed during in vivo laboratory testing
• exceptionally low skin irritation level comparable to deionised water
• tested in accordance with iso 10993: biological evaluation of medical devices,
part 10: tests for irritation and delayed-type hypersensitivity
• extended product testing for enhanced quality assurance
gammeX ® powder-free with amt has a fit so natural,
it feels like a secoNd skiN
thinner, softer latex with
shaped finger pads
for further sensitivity
optimal thumb positioning and a
larger thumb ball for enhanced
comfort and reduced fatigue
tapered straight cuff for
improved gown grip
ansell healthcare europe n.v.
riverside business park block j boulevard international 55
b-1070 brussels belgium tel.: +32 (0) 2 528 74 00 fax: +32 (0) 2 528 74 01
fax: customer service +32 (0) 2 528 74 03
http://www.ansell.eu e-mail: info@ansell.eu
GAMMEX ® powder-free Gloves with AMT Antimicrobial Technology contain natural rubber latex, which may cause allergic reactions.
GAMMEX ® powder-free Gloves with AMT Antimicrobial Technology are not proven to protect against blood-borne infections where the
skin is broken, cut, or punctured. Australia patent No. 703926 and New Zealand patent No. 556353. Au and worldwide patents pending.
Ansell, ® and are trademarks owned by Ansell Limited or one of its affiliates. © 2011 Ansell Limited. All rights reserved.
produced on ansell’s proprietary
anatomic formers for
a more natural fit
wider, textured palm for
better instrument grip
in damp and dry environments
neither this document nor any other statement made herein by or on behalf of ansell should be construed as a warranty of merchantability or that any ansell product is fit for
a particular purpose. ansell assumes no responsibility for the suitability or adequacy of an end user’s selection of gloves for a specific application.
about aNsell
ansell is a world leader in providing superior health and safety protection solutions that enhance human well being. with operations in north america, latin america, emea
and asia, ansell employs more than 10,000 people worldwide and holds leading positions in the natural latex and synthetic polymer glove and condom markets. ansell
operates in four main business segments: medical solutions, industrial solutions, new verticals & advanced concepts, and sexual health & well being. information on ansell
and its products can be found at http://www.ansell.eu
YGAMMEXAMTDETEN / GAMMEXAMT DETAILAID EN / 5000 / 09-11 / SSBC